DeFAI hiện đang hoạt động thế nào sau tất cả những lời đồn thổi? Tổng quan về tình hình hiện tại của sáu dự án phổ biến nhất

Gaugene

company

About

Gaugene provides hematology testing instruments, reagents, and services for IVD users.

Details

Last Funding Type
Series B
Last Funding Money Raised
¥100M
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 2017
Operating Status
Active

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥100M
Gaugene has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Jul 15, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 15, 2022 Series B ¥100M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Gaugene is funded by 2 investors. Anbiping and Huihe Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Anbiping Series B
Huihe Capital Series B